The COVID-19 and Cancer Consortium (CCC19) Registry

Purpose

To collect granular information on cancer patients infected with COVID-19.

Criteria

Suspected or lab-confirmed COVID-19          

               Current or past medical history of invasive malignancy

Details

Contact Principal Investigator for Information

Interested in more information? Contact Us:

Hematology Oncology Associates

IRB: Willis-Knighton
IRB Number: 20.0004
Trial Type: NA
Sponsor: Vanderbilt University Medical Center